M. L. Hansen Et Al. , "Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial," TRIALS , vol.20, no.1, 2019
Hansen, M. L. Et Al. 2019. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial. TRIALS , vol.20, no.1 .
Hansen, M. L., Pellicer, A., Gluud, C., Dempsey, E., Mintzer, J., Hyttel-Sorensen, S., ... Heuchan, A. M.(2019). Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial. TRIALS , vol.20, no.1.
Hansen, Mathias Et Al. "Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial," TRIALS , vol.20, no.1, 2019
Hansen, Mathias L. Et Al. "Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial." TRIALS , vol.20, no.1, 2019
Hansen, M. L. Et Al. (2019) . "Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial." TRIALS , vol.20, no.1.
@article{article, author={Mathias Luhr Hansen Et Al. }, title={Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial}, journal={TRIALS}, year=2019}